Artiva Biotherapeutics (ARTV) Leases (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Leases for 3 consecutive years, with $212000.0 as the latest value for Q4 2025.
- Quarterly Leases fell 18.77% to $212000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $212000.0 through Dec 2025, down 18.77% year-over-year, with the annual reading at $212000.0 for FY2025, 18.77% down from the prior year.
- Leases for Q4 2025 was $212000.0 at Artiva Biotherapeutics, down from $216000.0 in the prior quarter.
- The five-year high for Leases was $16.5 million in Q4 2023, with the low at $212000.0 in Q4 2025.
- Average Leases over 3 years is $5.9 million, with a median of $253500.0 recorded in 2024.
- Peak annual rise in Leases hit 18.77% in 2025, while the deepest fall reached 98.5% in 2025.
- Over 3 years, Leases stood at $16.5 million in 2023, then crashed by 98.42% to $261000.0 in 2024, then decreased by 18.77% to $212000.0 in 2025.
- According to Business Quant data, Leases over the past three periods came in at $212000.0, $216000.0, and $231000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.